TrialAntimicrobial agents and chemotherapy2018

Intrapulmonary Pharmacokinetics of Relebactam, a Novel β-Lactamase Inhibitor, Dosed in Combination with Imipenem-Cilastatin in Healthy Subjects.

Matthew L Rizk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.